Compound 1553
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1Cl)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(nc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1)C(F)(F)F
- InChi:
InChI=1S/C47H55Cl2F6N7O4S3/c1-45(2)20-15-31(37(26-45)30-9-11-32(48)12-10-30)27-61-22-17-34(18-23-61)62-24-19-36-40(28-62)57-44(46(50,51)52)58-43(36)59-69(65,66)35-13-14-39(42(25-35)68(63,64)47(53,54)55)56-33(16-21-60(3)4)29-67-41-8-6-5-7-38(41)49/h5-14,25,33-34,56H,15-24,26-29H2,1-4H3,(H,57,58,59)/t33-/m1/s1
- InChiKey:
KSTXEKPHQPXFHY-MGBGTMOVSA-N
External links
![]() 88540187 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 32 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.06 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 1061.28 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 9.75 | |||
TPSA | 127.84 | |||
RB | 17 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 32 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.06 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5877 | Navitoclax | DB12340 | |
0.4230 | Venetoclax | DB11581 | |
0.3787 | Vintafolide | DB05168 | |
0.3764 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | DB08039 | |
0.3740 | Presatovir | DB12165 | |
0.3680 | GDC-0349 | DB13072 | |
0.3569 | (4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol | DB08448 | |
0.3544 | Sulfaisodimidine | DB13283 | |
0.3520 | Henatinib | DB13019 | |
0.3497 | 2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID | DB07323 | |
0.3483 | Quinupristin | DB01369 | |
0.3459 | Bleomycin | DB00290 | |
0.3448 | Vinpocetine | DB12131 | |
0.3448 | Cyclothiazide | DB00606 | |
0.3433 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 |